Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q3 EPS of ($0.38), $0.07 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $2.02 million versus the consensus estimate of $3.08 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.